Overview

Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis

Status:
Completed
Trial end date:
2017-11-16
Target enrollment:
Participant gender:
Summary
A Study to evaluate efficacy and safety in subjects with moderate to severe Psoriasis treated with BMS-986165
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
BMS-986165